Skip to content

Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure

Tom’s Weight LossRankings
CompoundedNot tested · not scored

Alloy Women's Health

Alloy

Alloy offers a compounded GLP-1 range — semaglutide, tirzepatide and liraglutide — positioned within a broader women's midlife and menopause health service. Pricing was not clearly published on the page we captured.

Sources captured · researched by Tom

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

  • Compounded semaglutideCompounded · not FDA-approved
  • Compounded tirzepatideCompounded · not FDA-approved
  • Compounded liraglutideCompounded · not FDA-approved

What they publish

Alloy Women's Health publishes 0 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee
Not clearly published on the page we captured.
Medication cost
Not clearly published on the page we captured.
Introductory offer
Not publicly disclosed on the pages we captured.
Insurance
Not publicly disclosed on the pages we captured.
HSA / FSA
Not publicly disclosed on the pages we captured.
Consultation process
Not publicly disclosed on the pages we captured.
Eligibility
Not publicly disclosed on the pages we captured.
Lab work
Not publicly disclosed on the pages we captured.
Pharmacy fulfilment
Not publicly disclosed on the pages we captured.
Shipping
Not publicly disclosed on the pages we captured.
Support services
Not publicly disclosed on the pages we captured.
Cancellation
Not publicly disclosed on the pages we captured.
Refunds
Not publicly disclosed on the pages we captured.

What stands out

  • Offers compounded liraglutide alongside semaglutide and tirzepatide — liraglutide is a daily rather than weekly injection, which is a meaningful practical difference.
  • Positioned specifically around women's midlife and menopause health rather than weight loss alone, which may suit people whose weight change is tied to that transition.
  • Pricing was not clearly published on the page we captured, so we cannot state it.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

  • Pricing was not published at capture — establish the full cost before starting an intake.
  • All GLP-1 products listed were compounded. Ask which pharmacy compounds them and whether it is a 503A or 503B facility.
  • Ask for the exact active ingredient including salt form.

May suit

Women seeking weight management inside a broader midlife and menopause service, who have discussed compounded medication with their own clinician.

Limitations

  • No FDA-approved GLP-1 route published.
  • Pricing, insurance, refund and cancellation terms were not published on the page we captured.

Frequently asked

Does Alloy offer brand-name GLP-1s?

The page we captured listed compounded semaglutide, tirzepatide and liraglutide. We did not find a brand-name GLP-1 route on that page. Confirm directly, as offerings change.

Sources

Captured . Pages change — check the current version before relying on anything here.

Worth comparing against

Brand-nameCompoundedInsurance support

Mochi Health

Mochi Health

Flat membership with medication billed separately, and clear on-page compounding disclosure

Membership
from $79/mo
Medication
Billed separately
Publishes7/12 terms
Compounded

Ivím Health

Ivím Health

Compounded-focused, with prepaid multi-month medication pricing and a published returns policy

Membership
from $75/mo
Medication
Billed separately
Publishes5/12 terms
Brand-nameCompounded

Lemonaid Health

Lemonaid Health

The lowest published membership fee in this set, with both compounded and brand-name routes

Membership
from $49/mo
Medication
Billed separately
Publishes3/12 terms